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Pyrrolidine dithiocarbamateMany pro-apoptotic factors, such as nuclear factor-kappa B (NF-κB) and Fas, play crucial roles in the process
of Leydig cell apoptosis, ultimately leading to male sterility, such as in Sertoli cell only syndrome (SCO) and
hypospermatogenesis. However, themolecularmechanismof such apoptosis is unclear. Recent reports onN-myc
downstream-regulated gene 2 (ndrg2) have suggested that it is involved in cellular differentiation, development,
and apoptosis. The unique expression of NDRG2 in SCO and hypospermatogenic testis suggests its pivotal role in
those diseases. In this study, we analyzed NDRG2 expression proﬁles in the testes of normal spermatogen-
esis patients, hypospermatogenesis patients, and SCO patients, as well as in vivo and in vitromodels, which
were Sprague–Dawley rats and the Leydig cell line TM3 treated with the Leydig cell-speciﬁc toxicant
ethane-dimethanesulfonate (EDS). Our data conﬁrm that NDRG2 is normally exclusively located in the cy-
toplasm of Leydig cells and is up-regulated and translocates into the nucleus under apoptotic stimulations
in human and murine testis. Meanwhile, transcription factor NF-κB was activated by EDS administration,
bound to the ndrg2 promoter, and further increased in expression, effects that were abolished by NF-κB in-
hibitor Pyrrolidine dithiocarbamate (PDTC). Furthermore, siRNA knock-down of ndrg2 led to increased pro-
liferative or decreased apoptotic TM3 cells, while over-expression of ndrg2 had the reverse effect. This study
reveals that ndrg2 is a novel gene that participates in Leydig cell apoptosis, with essential functions in tes-
ticular cells, and suggests its possible role in apoptotic Leydig cells and male fertility.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Spermatogenesis is a dynamic process that requires the coopera-
tion of distinct compartments of the testis, seminiferous tubules,
and the interstitial tissues [1]. Leydig cells constitute the majority of
interstitial cells and generate testosterone for spermatogenesis [1].
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rights reserved.of Leydig cell was observed in transgenic mouse over-expresses
human chorionic gonadotropin [2], while Leydig cell apoptosis was
found in the testes of maturation arrest (MA) and SCO patients [3].
Furthermore, such apoptosis often accompanied with massive germ
cell apoptosis, mostly due to abnormal hormone level. Thus, elucidating
themechanism of Leydig cell apoptosiswould help us to understand and
treat those diseases. Leydig cell apoptosis could be triggered by many
factors, including exposure to radiation, toxic substances, hypoxia, ische-
mia and stress [4–7]. To clarify the possible mechanism of Leydig cell
apoptosis both in vivo and in vitro, EDS has been used to stimulate Ley-
dig cell apoptosis [8]. Both the apoptosis of Leydig cells triggered by EDS
and decreased spermatogenesis are irrelevant in the apoptotic pathway
involving the bcl-2 gene family and p53 [9] but should be accounted for
in the Fas/Fas-L and caspase-3 system activation [3,10,11].
In this study, a novel gene, ndrg2, was investigated in Leydig cell
apoptosis due to its exclusive expression in Leydig cells among all tes-
ticular cells [12,13]. It was identiﬁed in a human brain cDNA library
by PCR-based subtractive hybridization in 1999, and is a member of
the differentiation-related NDRG family, which includes four mem-
bers, NDRG1, -2, -3, and -4 [14]. NDRG2 is expressed in brain, heart,
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the suppression of tumor cell proliferation due to its decreased ex-
pression in several types of tumors [15–20]. In the human lung cancer
cell line A549, ndrg2 is regulated by hypoxia-inducible factor 1 [21].
Its modulation by p53 in several tumor cell lines suggests that ndrg2
might participate in the apoptotic process [22]. More importantly,
NDRG2 has been correlated with Fas expression and Fas-mediated
cell death in gastric cancer cells [23]. Additionally, in two metastatic
tumor cell lines, inhibition of NDRG2 affects the activation of NF-κB
[24], a classical apoptotic factor and Fas downstream molecular [25].
NF-κB is also involved in Leydig cell apoptosis induced by glucocorti-
coid [26]. However, the connection between NF-κB and NDRG2 in
Leydig cells remains unclear. Thus, elucidating their regulation and
potential interaction, as a putative mechanism of Leydig cell apopto-
sis, might shed light on male sterility.2. Materials and methods
2.1. Testicular samples
Testicular specimens were obtained from 25 men with a normal
46, XY karyotype and with obstructive or nonobstructive azoosper-
mia who visited the male infertility clinic in Xi Jing Hospital (Xi'an,
China): 17 men with nonobstructive azoospermia and from 8 men
with obstructive azoospermia. The open testicular biopsy technique
was used to obtain these specimens. Informed consent was obtained
from all patients. Tissues were ﬁxed in Bouin's solution prior to pro-
cessing for parafﬁn embedding.Fig. 1. Histological analysis of NDRG2 and NF-κB in normal, congenital SCO, secondary SCO an
and hypospermatogenic testes. In testes with normal spermatogenesis, cells in the seminife
congenital and secondary SCO patients, all tubules contained only Sertoli cells. In hyposperm
genic epithelium was thinner. Arrows: healthy Leydig cells; solid arrowheads: apoptosis-lik
(B) Immunohistochemistry for NDRG2 in normal and aberrant testes. Intensive staining for
SCO, secondary SCO and hypospermatogenic testes, the signal for NDRG2 was located in th
staining in cytoplasm; solid arrowheads: Leydig cells with NDRG2 staining in the nuclei;
germ cells with NDRG2 staining in the nuclei. (C) Characterization of NF-κB expression in n
plasm of the healthy Leydig cells and nuclei of spermatogonia, whereas in two types of SCO
cells, Sertoli cells and germ cells. Both sections show two images at lower and higher magn
rowheads: Leydig cells with NF-κB staining in the nuclei; open arrowheads: Sertoli cells wit
nuclei. Data represent groups of patients (normal, n=8; congenital SCO, n=6; secondaryOn the basis of standard qualitative interpretations of hematoxylin
and eosin-stained sections (Fig. 1A), biopsies were classiﬁed as fol-
lows: normal (NOR; n=8), almost all tubules showed development
of more than 10 elongating spermatids in each tubule cross section;
hypospermatogenesis (n=6), all tubules showed deranged sper-
matogenesis; congenital SCO (n=6), all seminiferous tubules
showed deletion of germ cells in the epithelium, while Leydig cell ap-
pears to be normal in number and shape; secondary SCO (n=5), the
diameter of the tubules is variable, ranging from normal to very tiny
ones, and the Sertoli cells are diminished in number and highly al-
tered in shape, only a few Leydig cells can be seen around the tubules
[27]. The testicular specimens from obstructive azoospermia showing
normal spermatogenesis (NOR) were used as a control. For detailed
information of patients' serum testosterone level, see Table 1.
2.2. Plasmid and siRNA constructions
DNA fragments encoding NF-κB binding sites in the mouse ndrg2
promoter (−1943 bp to +249 bp) were ampliﬁed by PCR, using LA
Taq enzyme (Takara, Tokyo, Japan) and the mouse genome as tem-
plate with the following primers: F 5′-GC AGA TCT ATG AGG CAG
AGG CAG TTT-3′ and R 5′-GC AAG CTT ACA GCC AGG AGA CCA GAA-
3′. These fragments were cloned into the pGL3-luc vector (Promega,
MD, USA) with Bgl II and Hind III. The truncated vector was generated
either by Kpn I digestion (−1943 bp to −210 bp) or by PCR using
mouse ndrg2 promoter-pGL3-luc vector as template with following
primers: (−1463 bp to +249 bp) F 5′-GC AGA TCT GAG AAA A GA
ACA GAG GGA A AC-3′, R 5′-GC AAG CTT ACA GCC AGG AGA CCA
GAA-3′; (−995 bp to +249 bp) F 5′-GC AGA TCT CAG TCC ATC AACd hypospermatogenic testes. (A) HE staining of normal, congenital SCO, secondary SCO
rous tubules were well arranged, and elongated spermatids were seen. In testes of both
atogenic testes, the number of each stage of germ cells decreased, and the spermato-
e Leydig cells; open arrowheads: Sertoli cells; dual arrowheads: elongated spermatids.
NDRG2 was found in the cytoplasm of the healthy Leydig cells, whereas in congenital
e nuclei of Leydig cells, Sertoli cells and germ cells. Arrows: Leydig cells with NDRG2
open arrowheads: Sertoli cells with NDRG2 staining in the nuclei; dual arrowheads:
ormal and aberrant testes. Relatively intense staining for NF-κB was found in the cyto-
and hypospermatogenic testes, the signal for NF-κB was located in the nuclei of Leydig
iﬁcation, respectively. Arrows: Leydig cells with NF-κB staining in cytoplasm; solid ar-
h NF-κB staining in the nuclei; dual arrowheads: germ cells with NF-κB staining in the
SCO, n=5; hypospermatogenesis, n=6) (scale bars 50 μm).
Table 1
Analysis of NDRG2, NF-κB, TUNEL positive signals in Leydig cell nucleus and serum tes-
tosterone level from men with different histological diagnosis.
Diagnosis NDRG2
(%labeled
cells)
NF-κB
(%labeled
cells)
TUNEL
(%labeled
cells)
Serum T
(ng/ml)
Normal
spermatogenesis
0.24±0.12 1.35±0.72 0.19±0.07 8.47±1.14
Congenital SCO 37.95±7.58* 34.22±8.24* 39.47±9.36* 7.38±1.72
Secondary SCO 89.82±3.03* 92.35±2.59* 95.86±6.18* 5.53±0.57*
Hypospermatogenesis 22.83±5.27* 19.40±3.21* 15.19±7.13* 8.26±2.31
Note: Data are presented as mean±SEM. Three hundred cells were evaluated for each
patient. *Signiﬁcantly different from group of normal spermatogenesis. Pb0.05.
Table 2
Antibodies, vendors, applications and their working dilutions.
Antibody Vendor Application Working
dilution
Mouse anti-NDRG2
monoclonal antibody
Abnova, Taiwan IHC, IF 1:100
WB 1:300
Mouse ExtrAvidin
Peroxidase Staining Kit
Sigma-Aldrich, USA IHC 1:20
Rabbit anti-3β-HSD
polyclonal antibody
Santa Cruz
biotechnology Inc,
USA
IF 1:100
Tritc-conjugated goat
anti-mouse IgG
Sigma-Aldrich, USA IF 1:60
Cy5-conjugated donkey
anti-rabbit IgG
Chemicon, Millipore,
USA
IF 1:200
Mouse anti-NF-κB p65
monocolonal antibody
Santa Cruz
biotechnology Inc,
USA
IHC, IF 1:100
WB 1:500
FITC-conjugated goat
anti-mouse IgG
Sigma-Aldrich, USA IF 1:60
Mouse anti-Fas intracellular
fragment monoclonal antibody
Abcam, USA WB 1:200
Rabbit anti-caspase 3
polyclonal antibody
Abcam, USA WB 1:300
Rabbit anti-active-caspase-3
p17 polyclonal antibody
Bioworlde, USA WB 1:300
Mouse anti-α-tubulin (TU-16)
monocolonal antibody
Santa Cruz
biotechnology Inc,
USA
WB 1:1000
Rabbit anti-Histone H2A.X
(Ab-139) polyclonal antibody
Signalway Antibody,
USA
WB 1:300
IRDye 800 CW conjugated
goat anti-mouse IgG
Rockland Inc, IL, USA WB 1:15,000
IRDye 800 CW conjugated
goat anti-rabbit IgG
Rockland Inc, IL, USA WB 1:15,000
Antibodies used for various experiments as reported herein are listed. Note that these
antibodies cross-reacted with the corresponding rat and/or mouse proteins as noted by
the manufacturers if the source of antigens used to raise the antibodies was not from rats
or mouse. WB, Western blot; IHC, immunohistochemistry; IF, immunoﬂuorescence.
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(−449 bp to +249 bp) F 5′-GC AGA TCT GAC TCG GCT GAG GAG
GTA-3′, R 5′-GC AAG CTT ACA GCC AGG AGA CCA GAA-3′. The phRL-
CMV plasmid (Promega), which contains a Renilla luciferase gene
under the control of a constitutive SV40 promoter, served as the con-
trol vector. The ndrg2-pcDNA3.1 plasmid and was kindly provided by
Prof. Xinping Liu (Fourth Military Medical University, Xi'an, China).
All plasmids were veriﬁed by sequencing (AuGCT, Beijing, China).
The sequences of siRNAs (Gene-Pharma, Shanghai, China) used
were: mouse ndrg2 sense: U CAA CAG GAG ACU UCC AUG GUG
UGC; antisense: G CAC ACC AUG GAA GUC UCC UGU UGA; non-
silencing control (labeled with FAM) sense: UUC UCC GAA CGU GUC
ACG UTT; antisense: ACG UGA CAC GUU CGG AGA ATT; gapdh
sense: GUA UGA CAA CAG CCU CAA GTT; antisense: CUU GAG GCU
GUU GUC AUA CTT.
2.3. Animals and reagents
Sprague–Dawley male rats (90 days old) and c57BL/6J male mice
(60 days old) (Fourth Military Medical University, Xi'an, China)
were injected intraperitoneally with either a single dose of EDS
(75 mg/kg for rat as described previously [8]; 75 mg/kg, 150 mg/kg,
or 375 mg/kg for mouse), or with vehicle. PDTC (100 mg/kg body
weight) [28] was injected into rat abdominal cavity immediately
after EDS treatment. EDS was produced in our lab according to the
Jackson Lab protocol [29] in a vehicle of DMSO/H2O (1:3 v/v). Animals
were euthanized at 2 h, 6 h, 12 h, 24 h, 48 h, or 72 h (mouse groups
and PDTC groups only at 72 h) after treatment. One of the testes
was prepared for histologic examination; the other testis was imme-
diately frozen in liquid nitrogen until analysis. The Ethics Committee
for Animal Experiments of the Fourth Military Medical University ap-
proved all animal work and experimental protocols.
Reagents used in this study and their vendors are as follows: LA
Taq enzyme, PrimeScript RT reagent kit, SYBR Premix EX Taq II
(Takara); Bgl II, Kpn I and Hind III, Dual-Luciferase Reporter Assay
System (Promega); In Situ Cell Death Detection Kit, POD (Roche, PA,
USA); fetal bovine serum (FBS), horse serum, Lipofectamine 2000,
TRIzol reagent (Invitrogen, CA, USA); DMEM-F12, NE-PER nuclear
and cytoplasmic extraction reagents (Thermo, MA, USA); hematoxy-
lin and eosin-Y, PDTC, diaminobenzidine (DAB), DMSO (Sigma-Al-
drich, Shanghai, China); tumor necrosis factor-alpha (TNF-α,
provided by Prof. Yingqi Zhang, Fourth Military Medical University,
Xi'an, China); ﬂuorescein isothiocyanate (FITC)-labeled Annexin V
and propidium iodide (PI) (Bestbio, Shanghai, China); Cell-Light™
thymidine nucleotide analogue 5-ethynyl-2′-deoxyuridine (EdU)
staining kit (Ribobio, Guangzhou, China). Antibodies used are listed
in Table 2.
2.4. Puriﬁcation of Leydig cells
Rat Leydig cells were puriﬁed from the vehicle-, EDS- and/or
PDTC-treated testes by continual Percoll density-gradientcentrifugation, as described in our previous study [29]. The purity of
isolated Leydig cells was characterized by staining with anti-3β-
hydroxysteroid dehydrogenase (3β-HSD) antibody (see Table 2).
The puriﬁed Leydig cells (purity>92%) were used for the following
experiments.
2.5. Cell culture and transfection
The mouse Leydig cell line TM3 (American Tissue Culture Collec-
tion) was cultured in DMEM-F12, 2.5% FBS and 5% horse serum at
37 °C in a 5% CO2 atmosphere.
At 24–48 h after puriﬁcation, 2×105/ml cells were seeded into 6-
well plates and incubated with culture medium containing vehicle,
200 μmol PDTC and/or 1.0 mg/ml EDS, according to previous reports
[30,31]. For PCR and western blot, cells were lysed after 2 h, 6 h,
12 h, and 24 h, collected for RNA and protein extraction, and stored
at −80 °C.
All siRNAs and plasmids were transfected into cells with Lipofecta-
mine 2000. Transfection with the non-silencing control 5′-FAM-la-
beled siRNA and a green ﬂuorescent protein (GFP)-pcDNA3.1
plasmid demonstrated that 80%–90% and 60%–70%, respectively, of
the cells were transfected, as detected by ﬂuorescence microscopy
(Olympus IX71S8F-2, Tokyo, Japan) (Supplementary Fig. 1A, B, C
and D).
2.6. HE and immunohistochemistry
Parafﬁn sections of the testes were stained with hematoxylin for
3 min, followed by 1 min incubation with Clariﬁer I and Bluing Re-
agent, and then stained with eosin-Y for another 30 s. Apoptotic Ley-
dig cells were determined by morphology characteristics, such as lack
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brane, shrinkage of cell volume and formation of apoptotic bodies.
Relative Leydig cell number was obtained through ampliﬁcation
17β-HSD III (for primers, see Section 2.9), marker of the adult Leydig
cell [32].
For immunohistochemistry, the sections were blocked with 10%
normal goat serum for 1 h and probed with anti-NDRG2 antibody or
anti-NF-κB antibody at 4 °C overnight. Then they were incubated
with biotinylated goat anti-mouse IgG at room temperature for 2 h
and incubated with ExtrAvidin Peroxidase for 1 h. Positive staining
was detected with 0.05% DAB/0.01% H2O2 in 0.05 mol/l Tris–HCl buffer.
The EDS-treated rat testicular sections of NDRG2 were then counter-
stained with hematoxylin for 2 min, while this step was omitted for
NF-κB sections. The negative control group, in which one of the primary
antibodies was omitted and replaced with normal IgG, showed no im-
munoreactivity (Supplementary Fig. 2A). All photographs were taken
under a light microscope (ZEISS Imager M1, Germany).
2.7. Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) and immunoﬂuorescent analysis of the apoptotic Leydig cells
The expression of NDRG2 and 3β-HSD in apoptotic Leydig cells
post-EDS treatment both in vivo and in vitro was assessed by immu-
noﬂuorescence combined with TUNEL assay. TUNEL staining to iden-
tify apoptotic Leydig cell in situwas performed as instructed by the In
Situ Cell Death Detection Kit. After incubation with TUNEL reaction
mixture, those sections were labeled with the mixture of anti-
NDRG2 antibody and anti-3β-HSD antibody (see Table 2) at 4 °C
overnight. TRITC- or Cy5-conjugated secondary antibodies (see
Table 2) were mixed and added onto the sections for 2 h and then
cover-slipped. Two negative controls and a positive control were set
up according to themanufacturer's protocol (Supplementary Fig. 2B, C).
The spatial expression of NF-κB and NDRG2 after EDS and TNF-α
treatment was evaluated with immunoﬂuorescence using anti-
NDRG2 antibody or anti-NF-κB p65 antibody (see Table 2) at 4 °C
overnight. Then the slides were labeled with TRITC- or FITC-
conjugated goat anti mouse IgG (see Table 2) at room temperature
for 2 h and cover-slipped. The speciﬁcity of the antibody was con-
trolled by using normal IgG instead of the primary antibody (Supple-
mentary Fig. 2D).
All labeled sections were observed under a confocal laser-
scanning microscope (Olympus FV1000) with excitation at 488 nm
for FITC/apoptotic cells or NF-κB p65, 543 nm for TRITC/NDRG2 and
650 nm for Cy5/3β-HSD.
2.8. Protein extraction and western blot analysis
The lysates of collected tissues and cells were prepared in lysis
buffer containing 150 mM NaCl, 2 mM EGTA, 10% glycerol (v/v), and
1% Nonidet P-40 (v/v) at pH 7.4 under 22 °C. Samples were freshly
supplemented with a 100:1 (v/v) ratio of protease inhibitor cocktail
to phosphatase inhibitor cocktails 1 and 2. Proteins (40 μg) were sep-
arated by SDS-PAGE and transferred onto nitrocellulose membranes.
Membranes were saturated with Tris-buffered saline with 0.1%
Tween 20 and 3% bovine serum albumin (TBST-BSA) and were
probed with the appropriate antibodies (see Table 2). Equal protein
loading for tissue or whole-cell lysates was assessed by stripping
blots and reprobing with an anti-tubulin antibody or anti-histone an-
tibody (see Table 2) for nuclear extracts. Secondary antibodies conju-
gated to IRDye 800 CWwere detected by an Odyssey infrared imaging
system (LI-COR Inc, Lincoln, NE).
2.9. RNA extraction and quantitative real-time PCR analysis
Total RNA was extracted from the testis specimens and TM3 cells
using TRIzol reagent according to the manufacturer's instructions.Those RNAs were reverse-transcribed to cDNAs according to Takara's
reverse transcription system protocol. cDNAs were then ampliﬁed by
PCR using speciﬁc primers for mouse ndrg2 and 17β-HSD III: ndrg2 F
5′-T CGT GCG GGT TCA TGT GGA TGC-3′, R 5′-T GTG TCC GGG TGG
TTC AGA GCA-3′, product size 203 bp; 17β-HSD III F 5′-ATT TTA CCA
GAG AAG ACA TCT-3′, R 5′-GGG GTC AGC ACC TGA ATA ATG-3′,
product size 367 bp. The primer sequences for hprt1, B2M, gapdh,
which was used as internal quantitative controls for the
ampliﬁcation, were as follows: hprt1 F 5′-AGC TAC TGT AAT GAT
CAG TCA ACG-3′, R 5′-AG AGG TCC TTT TCA CCA GCA-3′, product
size 198 bp; B2M F 5′- C ATG GCT CGC TCG GTG ACC-3′, R 5′-AAT
GTG AGG CGG GTG GAA CTG-3′ product size 166 bp; gapdh F 5′-CC
AGG TTG TCT CCT GCG ACT TCA-3′, R 5′-GGG TGG TCC AGG GTT TCT
TAC TCC-3′, product size 189 bp. The PCR enzyme and reagents used
were SYBR Premix EX Taq II. Cycling conditions for ndrg2, hprt1,
B2M, and gapdh were 95 °C for 30 s, followed by 40 cycles of 95 °C
for 3 s and 60 °C for 30 s (ABI PRISM 7500 Real-Time PCR System,
Life Technologies, USA). The quantitative PCR was run in singleplex
in triplicate for each sample. Data were analyzed using the ABI
Prism 7500 SDS software and genormplus software (Biogazelle NV,
Zwijnaarde, Belgium) as previously described [33,34].
2.10. Quantiﬁcation of apoptosis
Apoptosis was quantiﬁed by ﬂow cytometry analysis. Brieﬂy,
2×105/ml TM3 cells were cultured in 6-well plates with medium
containing vehicle, PDTC (200 μmol) and/or EDS (1.0 mg/ml) for 2 h,
6 h, 12 h, or 24 h. Cells were collected by trypsinization and washed
with PBS. Apoptosis was measured by dual-color analysis of Annexin
V binding (green ﬂuorescence) and PI uptake (red ﬂuorescence)
using a FACSCalibur (Becton Dickinson, CA, USA) apparatus with exci-
tation and emission settings at 488 nm plus a 515 nm band pass ﬁlter
for ﬂuorescein detection and a ﬁlter at >600 nm for PI detection.
2.11. Luciferase reporter gene assay
A total of 104 cells/well of TM3 cells were seeded into 96-well
plates and were cultured for 24 h before transfection. Then 0.4 μg/
well pGL3-mouse ndrg2 promoter-luc plasmid or a pGL3-truncated
mouse ndrg2 promoter-luc plasmid was co-transfected with 0.1 μg/
well phRL-CMV plasmid into TM3 cells with 0.5 μl/well Lipofectamine
2000. Forty-eight hours later, cells were incubated with either TNF-α
(100 ng/ml), EDS (1.0 mg/ml), PDTC (200 μmol) or vehicle for 8 h.
Subsequently, cells were lysed, and activation of the pGL3-mouse
ndrg2 promoter-luc construct was measured using the Dual-
Luciferase Reporter Assay System according to the manufacturer's in-
structions. Luminescence was quantiﬁed using a GLOMAX™ 20/20
luminometer (Promega). Three independent experiments were
done at least in quadruplicate, and the luciferase values were normal-
ized to Renilla luminescence.
2.12. Preparation of cytoplasmic and nuclear extracts
The cytoplasmic and nuclear protein extracts were prepared with
the NE-PER nuclear and cytoplasmic extraction reagents according to
the manufacturer's instructions. Samples were stored at −80 °C for
western blot analysis.
2.13. Labeling and detecting the DNA of proliferating cells with 5-
ethynyl-2′-deoxyuridine (EdU) in vitro
The Cell-Light™ EdU staining kit was used for the in vitro labeling
of the nuclei of dividing cells. Negative controls with EdU incubation
omitted showed no positive signal (Supplementary Fig. 2E, F). Images
were acquired under a ﬂuorescence microscope (ZEISS Imager M1).
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ChIP assays were performed with the chromatin immunoprecipi-
tation assay kit (Millipore, Upstate, Temecula, CA) according to the
manufacturer's instructions. Brieﬂy, TM3 cells were seeded in 10-cm
culture dishes. After treatment with TNF-α (100 ng/ml), EDS
(1.0 mg/ml), PDTC (200 μmol) or vehicle for 2 h, cells were cross-
linked with 1% formaldehyde for 15 min and sonicated at 100 W fol-
lowed by centrifugation for 15 min at 13,000×g at 4 °C. Supernatant
(40 μl) was taken as an input control, and the rest of the sample
was pre-cleaned with 75 μl agarose/salmon sperm and divided into
four portions. Two micrograms of immunoprecipitating antibody
against NF-κB (see Table 2) and normal rabbit IgG was added to
each portion. After overnight incubation at 4 °C, antibody–histone–
DNA complexes were sequentially washed with low-salt buffer,
high-salt buffer, LiCl immune buffer, and TE buffer. Precipitates
were eluted and incubated at 65 °C overnight to reverse formalde-
hyde cross-linking by adding 20 μl 5 M NaCl. DNA was puriﬁed by phe-
nol/chloroform extraction and ethanol precipitation. The chromatin
fragments were ampliﬁed by PCR using primers ﬂanking the NF-κB
binding sites of the ndrg2 promoter as follows: (−1856 to −1735) F
5′-A GGT CTA GGA AGT AAA CAG ATC-3′, R 5′-A GGT TCC AGC ATC
TAA ATC-3′, product size 122 bp; (−1340 to −1161) F 5′-CTC CTC
CTC CTC CCT CTT-3′, R 5′-CTG CCA ACT GCA ACA CCA-3′, product size
180 bp; (−702 to−557) F 5′-CCA CCC TTG CAG AGT TAG-3′, R 5′-GAAFig. 2. TUNEL assays in normal, SCO and hypospermatogenic testes. In situ TUNEL assay and imm
and hypospermatogenic testes. These sections were visualized using TUNEL (green), TRITC (re
mainly in the cytoplasm of Leydig cells in testes of normal spermatogenesis, while the si
hypospermatogenic and both types of SCO testes. Colocalization of NDRG2 immunoreact
in the overlay image. Arrows: Leydig cells with TUNEL, NDRG2, and DAPI signal in the nu
DAPI staining; open arrowheads: Sertoli cells with TUNEL, NDRG2 and DAPI signal in the
cleus. Data represent groups of patients (normal, n=8; congenital SCO, n=6; secondaryGGA GGG GAA AGA TGA-3′, product size 146 bp; (−463 to−352) F 5′-
AGA GCA AGC GGC GGG ACT-3′, R 5′-CTC GGG GCA GGT ATG GGT-3′,
product size 117 bp.
2.15. Statistical analysis
One-way ANOVA followed by Scheffe's F test (for multiple com-
parisons) or two-way ANOVA (for entire curves) was performed to
compare the effects of treatments on experiments with >2 treatment
groups. Student's t test was used to compare 2 group-design experi-
ments. Statistical analyses were performed with SPSS software (ver-
sion 10.0; SPSS, Chicago, IL). Results are presented as mean±SEM
from at least three independent experiments unless otherwise stated.
Statistical signiﬁcance was deﬁned as Pb0.05.
3. Results
3.1. Expression of NDRG2 and NF-κB in normal and infertile human testes
HE staining of normal and infertile testes served as standards of
diagnosis (Fig. 1A). In the case of normal spermatogenesis, NDRG2
expression was detected in the cytoplasm of interstitial Leydig cells
(Fig. 1B). In hypospermatogenic testes, intensive NDRG2 immunos-
taining was observed in the nuclei of Leydig cells and degenerating
germ cells (Fig. 1B), while NDRG2 expression was strongly detectedunoﬂuorescent localization of NDRG2 and DAPI in normal, congenital SCO, secondary SCO
d), and DAPI (blue). Confocal images indicate that NDRG2 immunoreactivity was present
gnal for NDRG2 also resided in apoptotic Leydig cells, germ cells and Sertoli cells in
ivity (red) with TUNEL labeling (green) and DAPI (blue) is indicated by white color
cleus; solid arrowheads: Leydig cells with cytoplasmic NDRG2 staining and nuclear
nucleus; dual arrowheads: germ cells with TUNEL, NDRG2 and DAPI signal in the nu-
SCO, n=5; hypospermatogenesis, n=6) (scale bars 50 μm).
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(Fig. 1B). Relatively intensive NF-κB staining was found in the inter-
stitial Leydig cells of testes with normal and abnormal spermatogen-
esis (Fig. 1C). The positive NF-κB staining in the seminiferous tubules
was conﬁned to the nuclei of Sertoli cells and germ cells of testes of
both types of SCO and hypospermatogenesis (Fig. 1C). Table 1 listed
all the positive staining rate of NDRG2 and NF-κB in Leydig cells of con-
genital SCO, secondary SCO, hypospermatogenesis and normal testes.
The absence of TUNEL staining in normal testes was accompanied
by restricted expression of NDRG2 only in the cytoplasm of Leydig
cells. TUNEL assays also conﬁrmed the immunohistochemistry results
that NDRG2 was localized in the apoptotic Leydig cells, Sertoli cells
and germ cells, as intensive staining for TUNEL and NDRG2 coloca-
lized in the DAPI-labeled nuclei of such cells (Fig. 2). For patients Ley-
dig cell apoptosis rate, see Table 1.
3.2. Expression of NDRG2 and NF-κB in EDS-treated murine testes
Exposure to EDS gradually eliminates Leydig cells from rat testis
for 72 h [8,10,11,30], so it was used in this study to mimic Leydig
cell apoptosis. In the testes with intraperitoneal EDS (75 mg/kg) ad-
ministration, HE staining and real-time PCR results indicated rat Ley-
dig cell hypoplasia (Fig. 3A and B). Leydig cells started to degenerate
gradually at 2 h after EDS treatment (98.93% as many Leydig cells as
control group) (Fig. 3A and B). Twenty-four hours later, this ratio
dropped to 28.54% (Fig. 3A and B). Finally, 72 h post–EDS treatment,
Leydig cells almost disappeared (8.35% compared to control group)
(Fig. 3A and B). However, after PDTC (100 mg/kg) and EDS treatment
for 72 h, Leydig cells had been protected from apoptosis (97.85% com-
pared to control group) (Fig. 3A and B). ImmunohistochemistryFig. 3. Testicular structure of EDS- and/or PDTC-treated testes. (A) HE staining of a vehicle
tration of 75 mg/kg EDS (vehicle used for EDS, DMSO:H2O=1:3) and/or PDTC (100 mg/kg
logical sign of apoptosis, 6 h post-EDS treatment. Addition of PDTC for 72 h protected Le
tissue compared with testis 72 h post-EDS treatment. Both sections show two images at lo
apoptotic Leydig cells. Data represent groups of rats (n=5 per group) (scale bars 50 μm). (
cell, after EDS and/or PDTC treatment. Data are presented as mean±SEM and are represe
**Pb0.01 compared to the control group, one-way ANOVA).demonstrated that in control testes, NDRG2was foundmainly in the cy-
toplasm of Leydig cells (Fig. 4A), as observed in human testes with nor-
mal spermatogenesis. As described in testes with hypospermatogenesis
and SCO, intense staining of NDRG2 was detected in the nuclei of
apoptosis-like Leydig cells and germ cells at 6 h to 48 h post-EDS
(Fig. 4A). Similar to NDRG2, NF-κB was also located in the cytoplasm
and nuclei of Leydig cells and germ cells after EDS stimulation
(Fig. 4B). These effects were also abolished by PDTC together with EDS
injection (Fig. 4A and B). Furthermore, we examined the expression
and distribution of NDRG2 and NF-κB in cultured TM3 cells treated
with EDS (1.0 mg/ml). NDRG2 andNF-κB immunoreactivitywas located
in the cytoplasm of healthy TM3 cells (see Section 3.4).
As described in hypospermatogenic and SCO testes, TUNEL and
immunoﬂuorescence staining for NDRG2 and 3β-HSD (marker of Ley-
dig cells) were performed in the in vivo and in vitromodels of apopto-
tic Leydig cells induced by EDS and/or PDTC. NDRG2 staining was
localized predominantly in the cytoplasm of Leydig cells. Meanwhile,
the colocalization of apoptotic cells (green), NDRG2-positive cells
(red), and 3β-HSD–positive cells (blue) revealed that NDRG2 expres-
sion in apoptotic Leydig cells or cultured TM3 cells was induced by
EDS administration (Fig. 5). In addition, at 6 h to 48 h post-EDS,
NDRG2 staining could also be found in the nuclei of Leydig cells
(Fig. 4A). As described in Section 3.1, apoptotic germ cells were ob-
served at 6 h, 12 h, and at their peak 24 h post-EDS, some of which
had positive signal representing NDRG2, indicated by yellow color
(Fig. 5). Nevertheless, simultaneous administration of PDTC and EDS
dramatically reduced Leydig and germ cell apoptosis, as indicated
by the absence of TUNEL signal in the testis (Fig. 5). For results of dif-
ferent doses of EDS treated mice testicular structures, NDRG2 and NF-
κB localization, see Supplementary Fig. 3.control SD rat and rats 2 h, 6 h, 12 h, 24 h, 48 h and 72 h after intraperitoneal adminis-
, diluted in H2O). Leydig cells show condensation of the nuclear chromatin, a morpho-
ydig cell viability, as conﬁrmed by the restored Leydig cell number in the interstitial
wer and higher magniﬁcation, respectively. Arrows: healthy Leydig cells; arrowheads:
B) Linear chart representing relative mRNA level of 17β-HSD III, marker of adult Leydig
ntative of three independent experiments in each group (n=5 per group) (*Pb0.05,
Fig. 4. NDRG2 and NF-κB expression in EDS- and/or PDTC-treated rat testes. (A) Immunolocalization of NDRG2 expression in the testis of control rats and rats sacriﬁced after 75 mg/
kg EDS and/or 100 mg/kg PDTC treatment. In the control and PDTC (±EDS)-treated testis, NDRG2 was localized in the cytoplasm of the Leydig cells, while after only EDS admin-
istration, the signal for NDRG2 appeared in the nuclei of Leydig cells and germ cells with condensed nuclear chromatin. (B) NF-κB expression in testis after EDS and/or PDTC treat-
ment. In the control and PDTC (±EDS)-treated testis, NF-κB was mainly localized in the cytoplasm of the Leydig cells and spermatogonia. After simply EDS stimulation, signal for
NF-κB appeared in the nuclei of Leydig cells and spermatogonia with condensed nuclear chromatin. Both sections show two images at lower and higher magniﬁcation, respectively.
Arrows: Leydig cells with positive signal for NDRG2 or NF-κB only in cytoplasm; arrowheads: Leydig cells with positive signal for NDRG2 or NF-κB both in cytoplasm and nucleus;
dual arrowheads: germ cells with positive signal for NDRG2 or NF-κB. Data represent groups of rats (n=5 per group) (scale bars 50 μm).
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Annexin V/PI staining showed that EDS cytotoxicity increased
with incubation time in Leydig cells. In TM3 cells, apoptotic cells con-
stituted 1.7% in the control group and 25.65%, 33.57%, 35.68% and
39.40% in the 2 h, 6 h, 12 h and 24 h EDS-treated groups, respectively
(Fig. 6A and B). However, the apoptotic rate of TM3 cells in the PDTC
(200 μmol) plus EDS treatment group decreased to 1.6%, 1.9%, 2.5%,
2.7% and 6.1%, from 2 h to 24 h post-treatment, respectively (Fig. 6AFig. 5. TUNEL assays in testes and cells with EDS and/or PDTC treatment. Immunoﬂuorescent
cells in the testis of adult rats before and 2 h, 6 h, 12 h, 24 h, 48 h and 72 h after 75 mg/kg ED
These sections and cell slides were visualized using TUNEL (green), TRITC (red), and CY5 (b
HSD-containing Leydig cells in the EDS and/or PDTC groups, while the signal for NDRG2 also
noreactivity (red) with TUNEL labeling (green) or a 3β-HSD-positive signal (blue) is indica
NDRG2 nuclear labeling as well as cytoplasmic 3β-HSD signal; Arrowheads: germ cells with
in the nucleus. Data represent groups of rats (n=5 per group) (scale bars 50 μm in testicuand B), which suggests that in vitro Leydig cell apoptosis triggered
by EDS could be alleviated by blocking NF-κB.
To further analyze the dynamic pattern of NDRG2 expression in apo-
ptotic Leydig cells in vivo, western blot and real-time quantitative PCR
were performed in lysates of puriﬁed Leydig cells collected from testes
2 h, 6 h, 12 h and 24 h after EDS treatment. The anti-NDRG2 immunore-
active band of about 42 kDa appeared similar to the vehicle-treated
group 2 h post-EDS and started to increase in intensity during the next
22 h, ﬁnally reaching its peak at 24 h, when its intensity dramaticallylocalization of NDRG2 and 3β-HSD by in situ TUNEL assay for the presence of apoptotic
S and/or 100 mg/kg PDTC treatment as well as cell slides incubated with 1.0 mg/ml EDS.
lue). Confocal images indicate that NDRG2 immunoreactivity is present mainly in 3β-
resided in apoptotic germ cells 12 h to 72 h post-EDS. Colocalization of NDRG2 immu-
ted by yellow or pink color in the overlay image. Arrows: Leydig cells with TUNEL and
TUNEL labeling in nucleus; dual arrowheads: germ cells with TUNEL and NDRG2 signal
lar sections, 20 μm in TM3 cell slides).
Fig. 6. Apoptosis of TM3 cells and dynamics of NDRG2 expression after exposure to EDS. (A, B) FACS scan results indicate the apoptosis rate after TM3 cells were incubated with
culture medium containing vehicle, 200 μmol PDTC and/or 1.0 mg/ml EDS for 2 h, 6 h, 12 h or 24 h. The percentage of apoptotic cells in the EDS group are 1.7% for vehicle treatment,
25.65% for 2 h EDS, 33.57% for 6 h, 35.68% for 12 h, and 39.40% for 24 h. The percentage of apoptotic cells in the PDTC+EDS group are 1.6%, 1.9%, 2.5%, 2.7% and 6.1%, from 2 h to 24 h
post treatment, respectively. (C, D) Western blot and histogram for NDGR2 expression in lysates of puriﬁed Leydig cells after exposure to vehicle, EDS and/or PDTC. (F, G) Western
blot and histogram for NDGR2 expression in whole-cell lysates from TM3 cells incubated with culture medium containing vehicle or EDS. (I, J) Western blot and histogram for
NDGR2 expression in whole-cell lysates from TM3 cells incubated with culture medium containing PDTC and/or EDS. α-Tubulin served as internal control. (E, H, K) Real-time
PCR using RNA collected from the above tissue and cell samples. Data are presented as mean±SEM and are representative of three independent experiments of each group
(n=5 per group) (*Pb0.05, **Pb0.01 compared to the control group, ¶Pb0.05, two-way ANOVA).
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ed TM3 cells 2 h, 6 h, 12 h and 24 h post–EDS treatment. The relative
protein level of NDRG2 increased 2 h after the EDS exposure and reached
its peak at 24 h, in agreement with the in vivo model (Fig. 6F and G).
However, the relative level of NDRG2 when PDTC was intraperitoneally
injected or added into the culture medium remained constant from 2 h
to 24 h (Fig. 6C, D, I and J). The PCR results were consistent with western
blot analysis (Fig. 6E, H and K). These results combined with quantiﬁca-
tion of apoptosis by ﬂow cytometer corroborate the ﬁnding that the pro-
tein level of ndrg2was elevated in apoptotic Leydig cells, which could be
blocked by PDTC.
3.4. Nuclear translocation of NDRG2 and NF-κB in EDS-induced apoptotic
Leydig cells
The activation and translocation of NF-κB and NDRG2 in EDS-
induced apoptotic Leydig cellsweremeasured by immuno-ﬂuorescenceand western blot. FITC-labeled NF-κB and TRITC-labeled NDRG2 sig-
nal were detected in the nuclei of most Leydig cells after incubation
with EDS (1.0 mg/ml) or TNF-α (100 ng/ml, as positive control) for
2 h (Fig. 7A). In the vehicle-treated groups, NF-κB and NDRG2
remained in the cytoplasm (Fig. 7A). In addition, nuclear protein
was extracted after TM3 cells were treated with EDS, TNF-α or vehi-
cle for 30 min, 1 h, or 2 h. The relative levels of NDRG2 and NF-κB in-
creased from 30 min to 2 h in the EDS-stimulated nuclei, while they
remained nearly constant in the TNF-α group (Fig. 7B and C). Mean-
while, the expression of NF-κB and NDRG2 in the cytoplasm extracts
conﬁrmed our earlier results that NDRG2 was up-regulated in both
the cytoplasm and nuclear extracts after 30 min to 2 h exposure to
EDS, while NF-κB level in the cytoplasm was decreasing, possibly
due to the nuclear translocation (Fig. 7D and E). Addition of vehicle
abolished such translocation (Fig. 7D and E). These results suggest
that NF-κB and NDRG2 translocated into the nucleus under stimula-
tion by EDS or TNF-α.
Fig.7. Nuclear translocation of NDRG2 and NF-κB in TM3 cells. (A) Differential interference contrast (DIC) and immunoﬂuorescent staining using TRITC (red) and FITC (green) to
represent NDRG2 (TRITC) and NF-κB (FITC) expression revealed NDRG2 and NF-κB translocated into the nucleus after incubation with medium containing 1.0 mg/ml EDS or 100 ng/
ml TNF-α, but they did not in the control group (scale bars 10 μm). (B, C) The relative protein levels of NDRG2 and NF-κB were increased compared to the control group in nuclear
protein extracts of cells treated with EDS, but not TNF-α, as characterized by western blot using antibodies against NDRG2 and NF-κB. Histone H2A.X served as internal control for
nuclear extracts. (D, E) The relative protein level of NF-κB in cytoplasm decreased when cells were stimulated by EDS, but not TNF-α, while the relative level of NDRG2 slightly
increased in the EDS group. α-Tubulin served as internal control. Data are presented as mean±SEM and are representative of three independent experiments of each group
(n=5 per group) (*Pb0.05, **Pb0.01 compared to the control group, one-way ANOVA).
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conjugation to its putative binding sites
Analysis of the−1943 bp to +250 bp region of the ndrg2 gene se-
quence, which contains the majority of the ndrg2 promoter region,
conﬁrmed the presence of ﬁve motifs that resembled the general con-
sensus binding site of NF-κB members (Fig. 8C). Thus, transient trans-
fection in the TM3 cell line was utilized to analyze whether NF-κB
could modulate transcription from the mouse ndrg2 promoter. The
basic relative promoter activity of full-length (−1943 bp to +249 bp)
mouse ndrg2 promoter was signiﬁcantly higher than truncated pro-
moters when TM3 cells were stimulated by TNF-α or EDS for 8 h
(Fig. 8B). The incubation time was based on our preliminary experi-
ments with TNF-α or EDS stimulation for 2 h, 4 h, 6 h, 8 h, which
showed that the promoter activity was highest at 8 h (data not
shown). Deletion of bp−1943 to−210 by Kpn I digestion completely
abrogated the transcriptional activation triggered by NF-κB (Fig. 8B).
This indicates the absence of effective NF-κB-responsive motifs
between bp −210 and +249, as the putative binding sites in this
region only exist on a single strand of DNA, while other putative sitesare predicted to be equally strong on both strands. In addition,
deletion of−1943 bp to−1463 bp,−1943 bp to−995 bp,−1943 bp
to−449 bp signiﬁcantly reduced transcriptional activity of luc, possibly
due to the loss of functional NF-κB binding sites (Fig. 8B). Addition of
PDTC eliminated the differences in the promoter activities of the EDS,
TNF-α and control groups, further supporting that NDRG2 is a regulator
of apoptosis and is transcriptionally activated by NF-κB (Fig. 8B).
ChIP was used to conﬁrm the conjugation of NF-κB to the NDRG2
promoter. The PCR results, in agreement with the luciferase reporter
gene assay, indicated the binding of NF-κB to four putative binding
sites in the NDRG2 promoter, while PDTC groups and negative control
groups that received normal IgG or anti-α-tubulin antibody showed
no such binding (Fig. 8A).
3.6. NDRG2 inhibition attenuates EDS-induced TM3 cell apoptosis and
promotes cell growth
By blocking NDRG2 expression with siRNA, NDRG2 expression de-
creased about 60% as detected by western blot (Fig. 9A and B). Analysis
of these samples with activated caspase-3 antibody demonstrated
Fig. 8. NF-κB binding activity to the ndrg2 promoter in response to EDS and TNF-α. (A) Detection of NF-κB binding in the ndrg2 promoter in response to 1.0 mg/ml EDS, 100 ng/ml
TNF-α or 200 μmol PDTC in TM3 cells by ChIP. Speciﬁc primers to the ndrg2 promoter ampliﬁed regions containing NF-κB binding sites. The input represents the ampliﬁcation of the
unprecipitated DNA. PCR ampliﬁcation of irrelevant immunoprecipitates with anti-α-tubulin antibody and normal rabbit IgG were used as negative controls. (B) Elevation of NF-κB-
dependent ndrg2 transcriptional activity induced by EDS and TNF-α in TM3 cells. Cells were co-transfected with pGL3-mouse ndrg2 promoter-luc or a pGL3-mouse ndrg2 truncated
promoter-luc construct along with the phRL-SV40 Renilla before treatment with EDS, TNF-α and/or PDTC, followed by lysis and luminescence detection. The relative ndrg2 tran-
scriptional activity of the full-length mouse ndrg2 promoter stimulated by both EDS and TNF-α was reduced through truncation and addition of PDTC. (C) Putative NF-κB binding
sites in the mouse ndrg2 promoter region. Altogether, 5 putative binding sequences of NF-κB are located in the mouse ndrg2 promoter region:−1831 to−1822,−1238 to−1229,
−644 to−635,−416 to−407, and−116 to−103. These sequences were analyzed by promoter-analyzing software, with the consensus NF-κB binding sequence GGGRNNYYCC
(N = any base, R = purine, Y = pyrimidine) as reference (red characters indicate bases of the promoter consistent with the consensus sequence), and ﬁnally cloned into the pGL3
vector. Data are mean±SEM of relative luciferase: Renilla activity (relative light units) for 4 determinations (*Pb0.05, **Pb0.01 compared to the control group, ¶Pb0.05, two-way
ANOVA).
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the relative level of total caspase-3 remained the same (Fig. 9A and B).
The extent of apoptosis after NDRG2 knock-down was quantiﬁed
by ﬂow-cytometric analysis in which TM3 cell lines were labeled
with Annexin V and PI. Incubation with EDS for 18 h induced
21.37% and 7.78% apoptotic TM3 cells in the non-silencing control
and RNAi groups, respectively, while the vehicle-treated RNAi group
showed 1.09% apoptotic cells, as compared to 1.23% in the vehicle-
treated non-silencing control group (Fig. 9C and D).
DNA ampliﬁcation was measured by EdU staining and detected by
confocal imaging. The results indicate that NDRG2 knock-down in
EDS-exposed groups increased the amount of proliferating cells
7.61% as compared to the non-silencing control groups, whereas in
vehicle-treated groups, such effect was not observed (Fig. 9E and F).
3.7. NDRG2 over-expression aggravates EDS-induced TM3 cell apoptosis
and inhibits cell growth
To trigger NDGR2 over-expression, pcDNA3.1-ndrg2 was trans-
fected into TM3 cells. Western blot indicated that the relative proteinlevel of NDRG2 was up-regulated by 40% (Fig. 9A and B). Active
caspase-3 increased compared to the control group, while total
caspase-3 remained unaltered (Fig. 9A and B).
Flow cytometry was performed to measure the apoptotic rate
after over-expression of NDRG2. NDRG2-over-expressing and non-
silencing siRNA transfected TM3 cells exposed to EDS for 18 h showed
62.46% and 21.37% apoptotic cells, respectively, while the vehicle-
treated NDRG2 over-expression group had 30.58% apoptotic cells,
compared to 1.23% in the vehicle-treated non-silencing control
group (Fig. 9C and D).
EdU staining further demonstrated that over-expression of
NDRG2 in vehicle or EDS-treated cells induced 23.72% or 28.39%
fewer proliferating cells, respectively, than without NDRG2 over-
expression (Fig. 9E and F).
4. Discussion
Apoptosis of Leydig cells, the main generator of testosterone pro-
duction in vivo, is characterized by the activation of the Fas/Fas ligand
system under certain circumstances [4–7]. Leydig cell apoptosis can
Fig. 9. Effects of NDRG2 knock-down and over-expression on TM3 cell proliferation and apoptosis. (A, B) NDRG2, total caspase-3, and activated caspase-3 expression after TM3 cells
were transfected with ndrg2-siRNA (N−) or ndrg2-pcDNA 3.1 plasmid (N+), as characterized by western blot. α-Tubulin was used as loading control. (C, D) FACS scan results in-
dicate the percentage of apoptotic TM3 cells induced by 1.0 mg/ml EDS stimulation after NDRG2 knock-down or over-expression. The percentage of apoptotic cells is 1.09% for
ndrg2-RNAi, 30.58% for NDRG2 over-expression, 7.78% for EDS-treated ndrg2-RNAi, 62.46% for EDS-treated NDRG2 over-expression, 21.37% for EDS, and 1.23% for vehicle-
treated untransfected cells. (E, F) NDRG2 knock-down promoted and over-expression inhibited Leydig cell growth in vitro. TM3 cells were transfected with ndrg2-pcDNA 3.1 or
ndrg2-siRNA, and then incubated with either vehicle or EDS solution. The proliferative percentages in the vehicle group are 62.92% for untransfected cells and 39.2% and 41.24%
for NDRG2 over-expression and knock-down, respectively, compared to 39.86% for EDS-treated untransfected cells and 11.47% and 47.48% for EDS-treated NDRG2 over-
expression and knock-down, respectively. Data are presented as mean±SEM. Data are representative of three independent experiments of each group (n=5 per group)
(*Pb0.05 compared to the control group, ¶Pb0.05, two-way ANOVA).
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patients [3]. Accordingly, EDS-induced Leydig cell apoptosis is a conse-
quence of Fas system activation [10,11]. Leydig cell apoptosis is not re-
lated to p53 activation due to its extremely low transcriptional activity
[35], but activation of NF-κB participates glucocorticoid induced Leydig
cell apoptosis [26]. However, the molecular mechanism of Leydig cell
apoptosis is still not fully understood. Here, we showed that in Leydigcells, NDRG2, regulated by NF-κB, is essential for cell death under the
stress of pro-apoptotic factors and, for the ﬁrst time to our knowledge,
investigated the activity of NF-κB at the ndrg2 gene promoter.
Ndrg2 was traditionally considered a putative tumor suppressor
gene that could repress the growth of several tumor cell lines
[15–20,24,36–39]. Moreover, it is involved in p53- and HIF-related
apoptosis [21,22]. NDRG2 is expressed in Leydig cells in human testes
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the expression of NDRG2 in infertile testes. As we explored NDRG2
expression in infertile testes, we found that NDRG2 not only is
expressed in the cytoplasm of normal Leydig cells but also translo-
cates into the nuclei of apoptotic Leydig cells, Sertoli cells and germ
cells. To further elucidate NDRG2's functions in this process, EDS
was used to speciﬁcally induce Leydig cell degeneration. HE staining,
immunohistochemistry and immunoﬂuorescence combined with
TUNEL staining conﬁrmed that NDRG2 is located only in the cyto-
plasm of healthy Leydig cells, while it is expressed in both the cyto-
plasm and the nuclei of EDS-induced rat apoptotic Leydig cells or
TM3 cells. Accordingly, the expression of NDRG2 in apoptotic germ
cells, as a result of androgen deprivation triggered by EDS-induced
Leydig cell apoptosis, has been reported in MAA-induced germ cell
apoptosis [12]. Nevertheless, further studies should be done to under-
stand the mechanisms and effects of these expression changes.
NF-κB, a pro-apoptotic transcription factor, has been correlated
with the apoptosis of both Leydig and germ cells [40–44], but it has
not been shown to be involved in SCO, hypospermatogenesis or
EDS-induced Leydig cell apoptosis. In fact, NF-κB can be activated
through the Fas-stimulated activation of RIP-1 or pro-caspase-8 [25].
Thus, we hypothesized that NDRG2 is a regulator of apoptosis and is
up-regulated by NF-κB. This hypothesis was supported by our identiﬁ-
cation ofﬁve elements in thendrg2 promoter region thatwere extreme-
ly similar to or conformed to the consensus NF-κB speciﬁc binding
sequence, GGGRNNYYCC (N = any base, R = purine, Y = pyrimidine)
[45] (Fig. 9C). NF-κB has a similar expression proﬁle as NDRG2 in SCO,
hypospermatogenesis and EDS-treated testes, while it is stage-
speciﬁcally expressed in these testes [46]. In vivo and in vitro inhibition
of NF-κB by PDTC blocked Leydig cell apoptosis and altered the NDRG2
expression proﬁle. This intrigued us to further explore the regulation of
NDRG2 by NF-κB in Leydig cells.
To the best of our knowledge, there are no studies showing that
NDRG2 can be regulated by NF-κB. Here we report that under certain
doses of TNF-α and EDS, NF-κB translocated into the nucleus. This im-
plied that NF-κB could bind to the mouse ndrg2 promoter region and
regulate its expression. To conﬁrm our hypothesis, luciferase assays
and ChIP were used. The results conﬁrmed that NF-κB was not merely
activated by TNF-α and EDS, but it further elevated the relative tran-
scriptional activity from the ndrg2 promoter through conjugation to
its −1831 bp to −1822 bp, −1238 bp to −1229 bp, −644 bp
to −635 bp and −416 bp to −407 bp binding sites, which was
abolishedwhen truncated promoterswere used or NF-κBwas inhibited
by PDTC. In addition to NF-κB, NDRG2 appeared in the nuclei of Leydig
cells of SCO and hypospermatogenesis patients and cells treated with
TNF-α or EDS. These ﬁndings were conﬁrmed by TUNEL assays and
western blots of nuclear extracts. In fact, NDRG2 can translocate into
the nucleus under hypoxia stress, which is abolished by deleting
amino acids 101 to 178 [21]. However, further studies should be done
to understand the mechanisms and purposes of such translocation.
To conﬁrm our ﬁndings were not constricted only to human and
rat species, here we reported, for the ﬁrst time within our knowledge,
that a single injection of 375 mg/kg EDS triggered massive mouse
Leydig cell loss in vivo (Supplementary Fig. 3). NDRG2 and NF-κB ex-
pression were also characterized in these testes (Supplementary Fig.
3). Nevertheless, additional experiments should be done to evaluate
the difference between EDS mouse model and rat model.
Based on the previous postulation that NDRG2 might regulate
Leydig cell apoptosis through up-regulation by NF-κB, we con-
ﬁrmed this connection by over-expression and knock-down of
NDRG2. EDS-induced Leydig cell apoptosis was elevated and prolif-
eration reduced by NDRG2 over-expression. As expected, NDRG2
knock-down caused the reverse effect. These ﬁndings suggest that
NDRG2 might be a pivotal protein that participates cell apoptosis and
partly explain the high expression of NDRG2 in apoptotic Sertoli cells
and germ cells.All together, these data suggest that ndrg2might be a pivotal gene
that promotes Leydig cell apoptosis under NF-κB regulation. We pos-
tulate that EDS-induced Fas activation triggers detachment of NF-κB
from IκB through RIP and/or pro-caspase-8. NF-κB then translocates
into the nucleus and binds the promoter region of ndrg2, which fur-
ther elevates the protein level of NDRG2. NDRG2 can then translocate
back into the nucleus and have downstream effects, such as feedback
toward NF-κB or regulation of downstream genes. Further analysis of
NDRG2's functions in Sertoli cells and germ cells might reveal its role
in fertility and sterility and whether similar effects of NF-κB's
regulation of NDRG2 exist in other cells, organs and species.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbadis.2011.11.013
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